2,6-diaminopyridine derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S194000, C546S268100, C514S336000

Reexamination Certificate

active

07423051

ABSTRACT:
Novel 2,6-diaminopyridine derivatives of formulawherein R1and R2are as defined below, are disclosed. These compounds inhibit cyclin-dependent kinases. These compounds and their pharmaceutically acceptable salts and esters have antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors. This invention is also directed to pharmaceutical compositions containing such compounds and to methods of treating or controlling cancer, most particularly the treatment or control of breast, lung, colon and prostate tumors. Also disclosed are intermediates useful in the preparation of these novel 2,6-diaminopyridine derivatives.

REFERENCES:
patent: 6262096 (2001-07-01), Kim et al.
patent: 2003/0220326 (2003-11-01), Chong et al.
patent: WO 99/21845 (1999-05-01), None
patent: WO 01/19825 (2001-03-01), None
patent: WO 01/38315 (2001-05-01), None
patent: WO 01/79198 (2001-10-01), None
patent: WO 2004/074283 (2004-09-01), None
patent: WO 2005/051387 (2005-06-01), None
V. Mesguiche, et al., Bioorganic & Medicinal Chemistry Letters, vol. 13, pp. 217-222 (2003), XP002356484.
Sielecki T., et al., J. Med. Chem., 2000, vol. 43, pp. 1-18.
Lin, R. et al., Bioorganic & Medicinal Chemistry Letters, 2005, vol. 15(9) pp. 2221-2224.
Lin, R. et al., Journal of Medicinal Chemistry Letters, 2005, pp. A-D.
Harris, W. & Wilkinson, S., Emerging Drugs, 2000, vol. 5, pp. 287-297.
Dumas, J., Exp. Opin. Ther. Patents, 2001, vol. 11, pp. 405-429.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2,6-diaminopyridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,6-diaminopyridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,6-diaminopyridine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3990094

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.